Statistics for Sage Therapeutics (id:6422 SAGE)

Valuation metrics

Market cap

292.41M

Enterprise value

-246,896,352.00

Trailing P/E (ttm)

-0.57

Forward P/E

-1.15

PEG ratio

-1.15

Price/Sales (ttm)

2.75

Price/Book (mrq)

0.53

Enterprise Value/Revenue

-2.32

Enterprise Value/EBITDA

0.66

Overview

Shares outstanding

61.17M

Float

48.46M

Shares short

6.00M

% Held by insiders

0.12%

% Held by institutions

0.86%

Average volume (10 days)

679.37K

Average volume (90 days)

Price summary

52-Week low

4.62

52-Week high

28.26

52-Week change

-277.18%

Beta

0.92

50-Day moving average

6.96

200-Day moving average

12.35

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

September 30th, 2024

Profitability

Profit margin

97.50%

Operating margin

-852.52%

Operational effectiveness

Return on assets

-29.62%

Return on equity

-49.34%

Income statement

Revenue (ttm)

1.76

Revenue per share (ttm)

1.76

Quarterly revenue growth (yoy)

Gross profit (ttm)

84.30M

EBITDA

-371,152,000.00

Net income to common (ttm)

-337,593,984.00

Diluted EPS (ttm)

-5.57

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

569.15M

Total cash per share (mrq)

9.30

Total debt (mrq)

10.27M

Total Debt/Equity (mrq)

1.86

Current ratio (mrq)

1.00K%

Book value per share (mrq)

9.02

Cash flow

Cash flow statement

-320,152,992.00

Levered free cash flow (LFCF)

-217,678,368.00